股票代码：******
网站地图
The company implemented shareholding reform in December 2017. In Phase I, the company has built a biopharmaceutical production workshop meeting GMP standards, the largest laboratory animal center in Jiangxi Province, a provincial enterprise technology center, and an immune technology research and development center meeting GMP requirements.
Add:
Address: No. 198 Huoju Avenue, Jinggangshan Economic & Technological Development Zone, Ji’an, Jiangxi, China
Board Office:
Complaint & Report Hotline:
Pharmacovigilance Hotline:
Company Email:
Investor Relations:
International Sales Email:
Complaint/Report Email:
WeChat mini-site
WeChat official account
© Copyright 2025 Jiangxi Institute of Biological Products Inc. | SEO
Powered by www.300.cn